EQUASENS (EQS.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:EQS • FR0012882389

38.6 EUR
-1.2 (-3.02%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Overall EQS gets a fundamental rating of 6 out of 10. We evaluated EQS against 11 industry peers in the Health Care Technology industry. While EQS has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on EQS. Finally EQS also has an excellent dividend rating. With these ratings, EQS could be worth investigating further for value and dividend investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year EQS was profitable.
  • In the past year EQS had a positive cash flow from operations.
  • EQS had positive earnings in each of the past 5 years.
  • EQS had a positive operating cash flow in each of the past 5 years.
EQS.PA Yearly Net Income VS EBIT VS OCF VS FCFEQS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

  • EQS has a better Return On Assets (8.82%) than 66.67% of its industry peers.
  • EQS has a Return On Equity of 15.77%. This is amongst the best in the industry. EQS outperforms 91.67% of its industry peers.
  • The Return On Invested Capital of EQS (12.84%) is better than 91.67% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for EQS is significantly above the industry average of 8.41%.
Industry RankSector Rank
ROA 8.82%
ROE 15.77%
ROIC 12.84%
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
EQS.PA Yearly ROA, ROE, ROICEQS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • The Profit Margin of EQS (16.13%) is better than 75.00% of its industry peers.
  • In the last couple of years the Profit Margin of EQS has remained more or less at the same level.
  • The Operating Margin of EQS (20.02%) is better than 75.00% of its industry peers.
  • In the last couple of years the Operating Margin of EQS has declined.
  • EQS's Gross Margin of 68.81% is in line compared to the rest of the industry. EQS outperforms 41.67% of its industry peers.
  • EQS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.02%
PM (TTM) 16.13%
GM 68.81%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
EQS.PA Yearly Profit, Operating, Gross MarginsEQS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EQS is creating value.
  • The number of shares outstanding for EQS remains at a similar level compared to 1 year ago.
  • EQS has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, EQS has an improved debt to assets ratio.
EQS.PA Yearly Shares OutstandingEQS.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EQS.PA Yearly Total Debt VS Total AssetsEQS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • EQS has an Altman-Z score of 3.76. This indicates that EQS is financially healthy and has little risk of bankruptcy at the moment.
  • EQS has a Altman-Z score of 3.76. This is in the better half of the industry: EQS outperforms 66.67% of its industry peers.
  • The Debt to FCF ratio of EQS is 0.98, which is an excellent value as it means it would take EQS, only 0.98 years of fcf income to pay off all of its debts.
  • EQS's Debt to FCF ratio of 0.98 is fine compared to the rest of the industry. EQS outperforms 66.67% of its industry peers.
  • A Debt/Equity ratio of 0.09 indicates that EQS is not too dependend on debt financing.
  • EQS has a Debt to Equity ratio (0.09) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.98
Altman-Z 3.76
ROIC/WACC1.64
WACC7.84%
EQS.PA Yearly LT Debt VS Equity VS FCFEQS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.29 indicates that EQS should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.29, EQS is in line with its industry, outperforming 41.67% of the companies in the same industry.
  • A Quick Ratio of 1.20 indicates that EQS should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.20, EQS perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.2
EQS.PA Yearly Current Assets VS Current LiabilitesEQS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for EQS have decreased strongly by -13.90% in the last year.
  • Measured over the past 5 years, EQS shows a small growth in Earnings Per Share. The EPS has been growing by 5.12% on average per year.
  • The Revenue has been growing slightly by 4.45% in the past year.
  • Measured over the past years, EQS shows a small growth in Revenue. The Revenue has been growing by 6.45% on average per year.
EPS 1Y (TTM)-13.9%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.19% on average over the next years. This is quite good.
  • Based on estimates for the next years, EQS will show a small growth in Revenue. The Revenue will grow by 7.74% on average per year.
EPS Next Y11.67%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EQS.PA Yearly Revenue VS EstimatesEQS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
EQS.PA Yearly EPS VS EstimatesEQS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 16.08, EQS is valued correctly.
  • Compared to the rest of the industry, the Price/Earnings ratio of EQS indicates a rather cheap valuation: EQS is cheaper than 83.33% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.93, EQS is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 12.72, EQS is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of EQS indicates a rather cheap valuation: EQS is cheaper than 83.33% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of EQS to the average of the S&P500 Index (27.77), we can say EQS is valued rather cheaply.
Industry RankSector Rank
PE 16.08
Fwd PE 12.72
EQS.PA Price Earnings VS Forward Price EarningsEQS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EQS is valued cheaper than 83.33% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EQS indicates a somewhat cheap valuation: EQS is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.7
EV/EBITDA 7.73
EQS.PA Per share dataEQS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • EQS has a very decent profitability rating, which may justify a higher PE ratio.
  • EQS's earnings are expected to grow with 14.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.38
PEG (5Y)3.14
EPS Next 2Y15.06%
EPS Next 3Y14.19%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • EQS has a Yearly Dividend Yield of 3.14%.
  • EQS's Dividend Yield is a higher than the industry average which is at 2.30.
  • EQS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.14%

5.2 History

  • On average, the dividend of EQS grows each year by 8.00%, which is quite nice.
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
EQS.PA Yearly Dividends per shareEQS.PA Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • EQS pays out 51.82% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • EQS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP51.82%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EQS.PA Yearly Income VS Free CF VS DividendEQS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
EQS.PA Dividend Payout.EQS.PA Dividend Payout, showing the Payout Ratio.EQS.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EQUASENS

EPA:EQS (2/6/2026, 7:00:00 PM)

38.6

-1.2 (-3.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-05
Earnings (Next)04-29
Inst Owners11.7%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap585.56M
Revenue(TTM)224.73M
Net Income(TTM)36.26M
Analysts83.33
Price Target54.06 (40.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.14%
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.82%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.25%
PT rev (3m)8.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.17%
EPS NY rev (3m)-1.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.08
Fwd PE 12.72
P/S 2.61
P/FCF 15.7
P/OCF 12
P/B 2.55
P/tB 7.33
EV/EBITDA 7.73
EPS(TTM)2.4
EY6.22%
EPS(NY)3.04
Fwd EY7.86%
FCF(TTM)2.46
FCFY6.37%
OCF(TTM)3.22
OCFY8.33%
SpS14.81
BVpS15.16
TBVpS5.27
PEG (NY)1.38
PEG (5Y)3.14
Graham Number28.61
Profitability
Industry RankSector Rank
ROA 8.82%
ROE 15.77%
ROCE 15.76%
ROIC 12.84%
ROICexc 18.12%
ROICexgc 70.2%
OM 20.02%
PM (TTM) 16.13%
GM 68.81%
FCFM 16.6%
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.08%
ROICexc(5y)21.2%
ROICexgc(3y)48.92%
ROICexgc(5y)61.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexgc growth 3Y-28.73%
ROICexgc growth 5Y-12.2%
ROICexc growth 3Y-17.5%
ROICexc growth 5Y-11.29%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.98
Debt/EBITDA 0.32
Cap/Depr 70.06%
Cap/Sales 5.11%
Interest Coverage 250
Cash Conversion 79.48%
Profit Quality 102.89%
Current Ratio 1.29
Quick Ratio 1.2
Altman-Z 3.76
F-Score7
WACC7.84%
ROIC/WACC1.64
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.9%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
EPS Next Y11.67%
EPS Next 2Y15.06%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
EBIT growth 1Y-7%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year55.72%
EBIT Next 3Y25.38%
EBIT Next 5YN/A
FCF growth 1Y-36.45%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-30.97%
OCF growth 3Y0.02%
OCF growth 5Y3.18%

EQUASENS / EQS.PA FAQ

What is the ChartMill fundamental rating of EQUASENS (EQS.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA.


What is the valuation status of EQUASENS (EQS.PA) stock?

ChartMill assigns a valuation rating of 7 / 10 to EQUASENS (EQS.PA). This can be considered as Undervalued.


What is the profitability of EQS stock?

EQUASENS (EQS.PA) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for EQS stock?

The Price/Earnings (PE) ratio for EQUASENS (EQS.PA) is 16.08 and the Price/Book (PB) ratio is 2.55.


What is the expected EPS growth for EQUASENS (EQS.PA) stock?

The Earnings per Share (EPS) of EQUASENS (EQS.PA) is expected to grow by 11.67% in the next year.